{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:43:41Z","timestamp":1764967421113,"version":"3.46.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol"],"published-print":{"date-parts":[[1999,10,1]]},"DOI":"10.1001\/archderm.135.10.1279","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T16:22:40Z","timestamp":1048004560000},"page":"1279","source":"Crossref","is-referenced-by-count":10,"title":["Low-Dose 2-Chlorodeoxyadenosine for the Treatment of Mycosis Fungoides"],"prefix":"10.1001","volume":"135","author":[{"given":"Franz","family":"Trautinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Schwarzmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"H\u00f6nigsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"REF-DLT1099-8-1-1","unstructured":"ASavenLDPiroThe newer purine analogs.Cancer.19937234703483"},{"key":"REF-DLT1099-8-1-2","unstructured":"TMKuzelAHurriaESamuelsonPhase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.Blood.199687906911"},{"key":"REF-DLT1099-8-1-3","unstructured":"PABunnJrSJHoffmanDNorrisLEGolitzJLAelingSystemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the S\u00e9zary syndrome).Ann Intern Med.1994121592602"},{"key":"REF-DLT1099-8-1-4","unstructured":"DCBetticherAvon RohrDRatschillerFewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.J Clin Oncol.199816850858"},{"key":"REF-DLT1099-8-1-5","unstructured":"PABunnJrSILambergReport of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.Cancer Treat Rep.197963725728"},{"key":"REF-DLT1099-8-1-6","unstructured":"European Organization for Research and Treatment of CancerA Practical Guide to EORTC Studies.Brussels, BelgiumEORTC Central Office-Data Center1994"}],"container-title":["Archives of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/478027\/dlt1099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:33:57Z","timestamp":1764966837000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/478027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archderm.135.10.1279","relation":{},"ISSN":["0003-987X"],"issn-type":[{"type":"print","value":"0003-987X"}],"subject":[],"published":{"date-parts":[[1999,10,1]]}}}